209 related articles for article (PubMed ID: 16488015)
1. A novel approach for medical countermeasures to nerve agent poisoning in the guinea-pig.
Wetherell J; Price M; Mumford H
Neurotoxicology; 2006 Jul; 27(4):485-91. PubMed ID: 16488015
[TBL] [Abstract][Full Text] [Related]
2. Development of next generation medical countermeasures to nerve agent poisoning.
Wetherell J; Price M; Mumford H; Armstrong S; Scott L
Toxicology; 2007 Apr; 233(1-3):120-7. PubMed ID: 16979808
[TBL] [Abstract][Full Text] [Related]
3. Physostigmine and hyoscine improves protection against the lethal and incapacitating effects of nerve agent poisoning in the guinea-pig.
Wetherell J; Hall T; Passingham S
Neurotoxicology; 2002 Sep; 23(3):341-9. PubMed ID: 12387361
[TBL] [Abstract][Full Text] [Related]
4. Non-enzymatic pretreatment of nerve agent (soman) poisoning: a brief state-of-the-art review.
van Helden HP; Joosen MJ; Philippens IH
Toxicol Lett; 2011 Sep; 206(1):35-40. PubMed ID: 21554933
[TBL] [Abstract][Full Text] [Related]
5. Extrapolating from animal studies to the efficacy in humans of a pretreatment combination against organophosphate poisoning.
Levy A; Cohen G; Gilat E; Kapon J; Dachir S; Abraham S; Herskovitz M; Teitelbaum Z; Raveh L
Arch Toxicol; 2007 May; 81(5):353-9. PubMed ID: 17009047
[TBL] [Abstract][Full Text] [Related]
6. Continuous administration of low dose rates of physostigmine and hyoscine to guinea-pigs prevents the toxicity and reduces the incapacitation produced by soman poisoning.
Wetherell JR
J Pharm Pharmacol; 1994 Dec; 46(12):1023-8. PubMed ID: 7714714
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of antidotal effects of adamantyl derivative Tamorf in soman poisoning.
Lucić Vrdoljak A; Radić B; Garaj-Vrhovac V; Kopjar N; Zlender V
J Appl Toxicol; 2006; 26(1):56-63. PubMed ID: 16167315
[TBL] [Abstract][Full Text] [Related]
8. A novel approach to assessing percutaneous VX poisoning in the conscious guinea-pig.
Mumford H; Price ME; Wetherell JR
J Appl Toxicol; 2008 Jul; 28(5):694-702. PubMed ID: 18059069
[TBL] [Abstract][Full Text] [Related]
9. Cardiovascular effects of the adenosine A1 receptor agonist N6-cyclopentyladenosine (CPA) decisive for its therapeutic efficacy in sarin poisoning.
Joosen MJ; Bueters TJ; van Helden HP
Arch Toxicol; 2004 Jan; 78(1):34-9. PubMed ID: 14508639
[TBL] [Abstract][Full Text] [Related]
10. Bioscavenger is effective as a delayed therapeutic intervention following percutaneous VX poisoning in the guinea-pig.
Mann TM; Price ME; Whitmore CL; Perrott RL; Laws TR; McColm RR; Emery ER; Tattersall JEH; Green AC; Rice H
Toxicol Lett; 2018 Sep; 293():198-206. PubMed ID: 29183815
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of HI 6 treatment after percutaneous VR exposure by use of a kinetic-based dynamic computer model.
Aurbek N; Thiermann H; Szinicz L; Worek F
Toxicology; 2007 Apr; 233(1-3):173-9. PubMed ID: 16904808
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetic profile and quantitation of protection against soman poisoning by the antinicotinic compound MB327 in the guinea-pig.
Price ME; Docx CJ; Rice H; Fairhall SJ; Poole SJC; Bird M; Whiley L; Flint DP; Green AC; Timperley CM; Tattersall JEH
Toxicol Lett; 2016 Feb; 244():154-160. PubMed ID: 26325216
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of human serum butyrylcholinesterase against sarin vapor.
Saxena A; Sun W; Dabisch PA; Hulet SW; Hastings NB; Jakubowski EM; Mioduszewski RJ; Doctor BP
Chem Biol Interact; 2008 Sep; 175(1-3):267-72. PubMed ID: 18597747
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of the ketamine-atropine combination in the delayed treatment of soman-induced status epilepticus.
Dorandeu F; Carpentier P; Baubichon D; Four E; Bernabé D; Burckhart MF; Lallement G
Brain Res; 2005 Jul; 1051(1-2):164-75. PubMed ID: 16005443
[TBL] [Abstract][Full Text] [Related]
15. Effects of sarin on the operant behavior of guinea pigs.
Langston JL; Adkins AL; Moran AV; Rockwood GA; Deford MS
Neurotoxicol Teratol; 2005; 27(6):841-53. PubMed ID: 16046097
[TBL] [Abstract][Full Text] [Related]
16. Stoichiometric and catalytic scavengers as protection against nerve agent toxicity: a mini review.
Lenz DE; Yeung D; Smith JR; Sweeney RE; Lumley LA; Cerasoli DM
Toxicology; 2007 Apr; 233(1-3):31-9. PubMed ID: 17188793
[TBL] [Abstract][Full Text] [Related]
17. The pharmacokinetics and pharmacodynamics of two HI-6 salts in swine and efficacy in the treatment of GF and soman poisoning.
Lundy PM; Hill I; Lecavalier P; Hamilton MG; Vair C; Davidson C; Weatherby KL; Berger BJ
Toxicology; 2005 Mar; 208(3):399-409. PubMed ID: 15695025
[TBL] [Abstract][Full Text] [Related]
18. The effects of repeated low-dose sarin exposure.
Shih TM; Hulet SW; McDonough JH
Toxicol Appl Pharmacol; 2006 Sep; 215(2):119-34. PubMed ID: 16556454
[TBL] [Abstract][Full Text] [Related]
19. Evolution of and perspectives on therapeutic approaches to nerve agent poisoning.
Masson P
Toxicol Lett; 2011 Sep; 206(1):5-13. PubMed ID: 21524695
[TBL] [Abstract][Full Text] [Related]
20. Protection by a transdermal patch containing physostigmine and procyclidine of soman poisoning in dogs.
Kim WS; Cho Y; Kim JC; Huang ZZ; Park SH; Choi EK; Shin S; Nam SY; Kang JK; Hwang SY; Kim YB
Eur J Pharmacol; 2005 Nov; 525(1-3):135-42. PubMed ID: 16256978
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
